vanillylnonamide
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01708915)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Vanilloid receptorACTIVATOR
TRPV1 activator
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1- Mol. weight
- 293.41 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL75124 ↗
Also known as
- nonanoyl vanillylamide
- nonivamide
- nonivamide
- nonivamide
- nonivamide
- nonylic acid vanillylamide
- vanillylnonamide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02300311 | Phase 3 | Jan 1, 2015 | Boehringer Ingelheim |
| NCT01708915 | Phase 3 | Oct 1, 2012 | Boehringer Ingelheim |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 2 | 2 | 1 | 2012 |
1 organizations
Page 1 / 1